{"id":604745,"date":"2025-12-01T06:14:14","date_gmt":"2025-12-01T06:14:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/604745\/"},"modified":"2025-12-01T06:14:14","modified_gmt":"2025-12-01T06:14:14","slug":"australias-drug-regulator-issues-mental-health-warning-for-weight-loss-drugs-including-ozempic-health","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/604745\/","title":{"rendered":"Australia\u2019s drug regulator issues mental health warning for weight-loss drugs including Ozempic | Health"},"content":{"rendered":"

The medicines regulator has added two new safety warnings about mental health and contraception for people taking high-profile diabetes and weight loss drugs.<\/p>\n

The Therapeutic Goods Administration (TGA) says that because suicidal behaviour and ideation have been reported with these relatively new GLP-1 receptor agonists, doctors should \u201cmonitor patients for the emergence or worsening of depression, suicidal thoughts or behaviours, and\/or any unusual changes in mood or behaviour\u201d.<\/p>\n

The warning of the potential risk of suicidal thoughts applies across the GLP-1 RA class of medicines, including Ozempic, Wegovy, Saxenda, Trulicity and Mounjaro.<\/p>\n

Sign up: AU Breaking News email<\/a><\/p>\n

The TGA has also issued a separate warning around Mounjaro and contraception.<\/p>\n

After investigating the potential reduced effectiveness of oral contraception when first taking or increasing the dose of Mounjaro, the TGA said it could not rule out an association.<\/p>\n

As a precautionary measure, it has updated the product warnings for Mounjaro to include further advice for patients using oral contraceptives to switch to a non-oral contraceptive or add a barrier method of contraception for four weeks after first taking the medicine and for four weeks after each increase in the dose.<\/p>\n

It added that none of the GLP-1 RA class of medicine should be used during pregnancy.<\/p>\n","protected":false},"excerpt":{"rendered":"The medicines regulator has added two new safety warnings about mental health and contraception for people taking high-profile…\n","protected":false},"author":2,"featured_media":604746,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,4326,16,15],"class_list":{"0":"post-604745","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115642844093701333","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/604745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=604745"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/604745\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/604746"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=604745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=604745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=604745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}